I-Mab
Utility Patents

Last updated:

List of all I-Mab patents 12 in total

Status Patent
Grant
Utility: Anti-PD-L1 antibody and IL-7 fusions External link
Filling date: 6 Sep 2025 Issue date: 2 Aug 2022
Grant
Utility: Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 1 Mar 2022
Grant
Utility: Anti-PD-L1 antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Human PD-L1 antibodies External link
Filling date: 6 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Anti-IFNAR1 antibodies for treating autoimmune diseases External link
Filling date: 6 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Anti-CD73 anti-PD-L1 bispecific antibodies External link
Filling date: 6 Sep 2025 Issue date: 15 Jun 2021
Grant
Utility: Anti-CXCL13 antibodies External link
Filling date: 6 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Antibodies to T cell immunoreceptor with IG and ITIM domains (TIGIT) and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 13 Apr 2021
Grant
Utility: Anti-GM-CSF antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 12 Jan 2021
Grant
Utility: Anti-PD-L1 antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 28 Jul 2020
Grant
Utility: Anti-CD73 antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 10 Mar 2020
Grant
Utility: Anti-LAG-3 antibodies and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2020

Showing 1 to 12 of 12 patents.